Free 25-Vitamin D Is Correlated with Cardiovascular Events in Prevalent Hemodialysis Patients but Not with Markers of Renal Mineral Bone Disease.


Journal

Kidney & blood pressure research
ISSN: 1423-0143
Titre abrégé: Kidney Blood Press Res
Pays: Switzerland
ID NLM: 9610505

Informations de publication

Date de publication:
2019
Historique:
received: 22 02 2019
accepted: 10 03 2019
pubmed: 17 6 2019
medline: 7 1 2020
entrez: 17 6 2019
Statut: ppublish

Résumé

Free vitamin D is the biologically active form of vitamin D. Vitamin D deficiency is associated with cardiovascular disease, the most common cause of mortality in hemodialysis patients. The goal of our current study was to investigate the relation between blood concentrations of free 25-hydroxyvitamin D with cardiovascular events in end-stage chronic kidney disease patients on hemodialysis, because this is unknown so far. We measured free vitamin D levels in 117 stable consecutive prevalent patients in September as a surrogate of vitamin D exposure during the past 6 months, and recorded the number of cardiovascular events during the previous 6 months defined as hospitalization due to heart failure, episodes of acute coronary syndrome, and stroke. Fourteen events occurred during the observation period. In patients without any cardiovascular events the free vitamin D levels were significantly higher as compared to those with cardiovascular events (patients without events: 5.68 [4.37-9.27] pg/mL; patients with events: 4.74 [3.46-5.37] pg/mL, p = 0.015). This finding remained stable after multiple regression analysis considering confounding factors such as age, time on dialysis, preexisting diabetes, hypertension, and coronary heart disease. In conclusion, our study shows that free vitamin D serum concentrations are independently associated with major cardiovascular events in chronic kidney disease patients on dialysis.

Identifiants

pubmed: 31203281
pii: 000499878
doi: 10.1159/000499878
doi:

Substances chimiques

Biomarkers 0
Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-353

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Auteurs

Xin Chen (X)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.

Yong-Ping Lu (YP)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.

Ting Luo (T)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.

Hong-Wei Wu (HW)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.

Su-Fen Cai (SF)

Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China.

Mei Tian (M)

Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China.

Liang-Hong Yin (LH)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.

Bernhard K Krämer (BK)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.

Fan-Na Liu (FN)

Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.

Berthold Hocher (B)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany, berthold.hocher@medma.uni-heidelberg.de.
Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China, berthold.hocher@medma.uni-heidelberg.de.
Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China, berthold.hocher@medma.uni-heidelberg.de.

Saban Elitok (S)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Department of Nephrology and Endocrinology/Diabetology Potsdam, Klinikum Ernst von Bergmann, Potsdam, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH